Human Serpin E1/PAI-1 Alexa Fluor® 750-conjugated Antibody

Applications

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Preparation and Storage

Background: Serpin E1/PAI-1

As a member of the Serpin superfamily of serine protease inhibitors, Serpin E1/PAI-1 is the principal inhibitor of urokinase-type plasminogen activator (uPA) and tissue-type PA (1, 2). As important regulators of extracellular matrix remodeling, uPA and PAI-1 play a major role in many processes such as angiogenesis, tumor invasion and obesity (2-4). For example, uPA and PAI-1 are the only tumor prognostic factors validated at the highest level of evidence with regard to their clinical utility in breast cancer (5). The human PAI-1 is initially synthesized as 402 amino acid precursor with a N-terminal signal peptide (6, 7). PAI-1 may exist in one of two possible conformations, designated as active or latent (8). The purified recombinant human (rh) PAI-1 is active against rhuPA. The heterogeneity at the N-terminus of the purified rhPAI-1 has been observed before for both the recombinant and native proteins (9).

Product Datasheets

Related Research Areas

• Adipocytokines
• Alpha Granule Soluble Molecules
• Cancer Biomarkers
• Coagulation
• Complement Pathway
• DNA Damage and Repair
• Enzymes Secreted by Endothelial Cells
• Mesenchymal Cells and EMT
• Plasmin/Plasminogen and Kallikrein/Kinin Systems
• Search Cytokine and Growth Factor Products
• Serine Proteases and Regulators